topramezone
[3-(4,5-二氢-3-异噁唑基)-4-甲基磺酰-2-甲基苯]5-羟基-1-甲基-1H-吡唑-4-基)甲酮
,
苯吡唑草酮
,
[3-(4,5-二氢-3-异噁唑基)-2-甲基-4-(甲磺酰)苯基](5-羟基-1-甲基-1H-吡唑-4-基)甲酮
,
吡草磺, 4-[2-methyl-3-(4,5-dihydroisoxazol-3-yl)-4-methylsulfonylbenzoyl ]-1-methyl-5-hydroxy-1H-pyrazole, 4-[3-(4,5-dihydroisoxazol-3-yl)-4-methylsulfonyl-2-methylbenzoyl]-5-hydroxy-1-methylpyrazole, 4-[3-(4,5-dihydro-1,2-oxazol-3-yl)-2-methyl-4-methylsulfonylbenzoyl]-2-methyl-1H-pyrazol-3-one, Methanone, [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl](5-hydroxy-1-methyl-1H-pyrazol-4-yl)-, [3-(4,5-Dihydroisoxazol-3-yl)-2-methyl-4-(methylsulfonyl)phenyl](5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone, 11322047, T5NO EUTJ ER B1 FSW1 CV- DTNNJ A1 EQ, 1-methyl-4-(3-(4,5-dihydroisoxazol-3-yl)-2-methyl-4-methyl-sulfonylbenzoyl)-5-hydroxypyrazole, [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl](5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone, [3-(4,5-dihydro-1,2-oxazol-3-yl)-4-(methanesulfonyl)-2-methylphenyl](5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone, benzuocaotong, [3-(4,5-Dihydro-1,2-oxazol-3-yl)-2-methyl-4-(methylsulfonyl)phenyl](5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone, 4-[3-(4,5-dihydroisoxazol-3-yl)-2-methyl-4-methylsulfonyl-benzoyl]-1-methyl-5-hydroxy-1H-pyrazole, topramezone, [3-(4,5-dihydro-1,2-oxazol-3-yl)-4-mesyl-o-tolyl](5-hydroxy-1-methyl-1H-pyrazole-4-yl)methanone, [3-(4,5-dihydro-1,2-oxazol-3-yl)-4-mesyl-o-tolyl](5-hydroxy-1-methylpyrazol-4-yl)methanone, [3-(4,5-Dihydro-1,2-oxazol-3-yl)-2-methyl-4-(methylsulfonyl)phenyl](5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanon
CAS号: 210631-68-8
SMILES: CC1=C(C=CC(=C1C2=NOCC2)S(=O)(=O)C)C(=O)C3=CNN(C3=O)C
EINECS: -
国家地区 / 英文物质名
危险类别和项别
H代码
象形图
警示词
是否强制
操作
免责申明
1. CIRS努力保证内容的准确性并及时更新。但是，CIRS不对信息的质量、准确性、完整性或可靠性负责。
2. 在任何时候，CIRS不对因用户使用本数据库的信息导致的任何声明、损害或者损失负责以及承担责任。
3. CIRS保留在没有事先通知的情况下进行修改、修正、增加或者移除部分信息的权利。
